Pharmacology Research & Perspectives

期刊全称Pharmacology Research & Perspectives
期刊缩写Pharmacol. Res. Perspect.
涉及主题
(科研通AI识别)
医学生物内科学化学药理学生物化学遗传学内分泌学心理学物理有机化学精神科病理受体生物信息学基因外科计算机科学免疫学
期刊介绍

PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS

期刊ISSNprint: 2052-1707
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
2.92.62.9632.7942.052000
历年发表/被引量
(科研通AI通过大数据分析)
年份2025202420232022202120202019201820172016201520142013
发表量861511161442111481078299901028321
被引量12703001311829912594211513891143811546252415
h-Index0
自引率0.00%
涉及的研究领域Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
中科院2025年分区 ?
大类小类TOP期刊综述期刊
4区3区 药学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
PHARMACOLOGY & PHARMACYSCIEQ3202/352

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
PHARMACOLOGY & PHARMACYSCIEQ2158/353
期刊主页http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2052-1707https://bpspubs.onlinelibrary.wiley.com/journal/20521707
出版商Wiley-Blackwell
出版国家(地区)ENGLAND
出版语言English
每年出版文章数188
Gold OA文章占比67.87%
原创研究文献占比
(排除综述)
76.80%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

Directory of Open Access Journals (DOAJ)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2052-1707%5BISSN%5D
平均审稿周期20 Weeks
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈